|
FY2021
12 months to Dec 31, 2021
|
FY2020
3 months to Dec 31, 2020
|
|
|---|---|---|
| Cash Flows from Operating Activities: | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Interest earned on marketable securities held in Trust Account | ||
| Change in fair value of warrant liabilities | ||
| Offering costs allocated to warrants | ||
| Changes in current assets and current liabilities: | ||
| Prepaid assets | ||
| Other noncurrent assets | ||
| Accounts payable and accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities: | ||
| Investment of cash into trust account | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities: | ||
| Proceeds from issuance of Founder Shares | ||
| Proceeds from sale of Units, net of underwriting discount | ||
| Proceeds from issuance of Private Placement Warrants | ||
| Proceeds from promissory note – related party | ||
| Repayment of promissory note – related party | ||
| Payment of deferred offering costs | ||
| Net cash provided by financing activities | ||
| Net Change in Cash | ||
| Cash, end of the period | ||
| Cash, beginning of period | ||
| Cash, end of period | ||
| Supplemental disclosure of non-cash financing activities: | ||
| Accrued deferred offering costs | ||
| Deferred underwriters’ discount payable charged to additional paid-in capital |
Loading...
